BioSpace News Archive

Hanford Laboratory Management and Integration, LLC (HLMI)—a joint venture between Navarro Research and Engineering, Inc. (Navarro) and (ATL), a wholly-owned subsidiary of Planned Systems International, Inc. (PSI)—announced it was awarded a contract to run the 222-S Laboratory Complex at the Hanford Site located in Richland, WA.

Olive Pro’s modern design, unmatched pricing and smart AI technology is the ultimate hearing aids killer, offering affordable hearing for all.

As fall 2020 brings a surge of COVID-19 cases and concerns for hospital capacity, US infectious disease specialists have shifted their assessment of candidates leading the vaccine development race

Vancouver Coastal Health and Lower Mainland Biomedical Engineering win ECRI award for joint investigation into high-risk medication over-infusions

PharmaJet ® , the maker of innovative, needle-free injection technology, today announced that its Tropis ® Needle-free Injection System will be used by Diomics , a San Diego-based biotech company, to deliver a biopolymer to detect the formation of an immune response to a SARS-CoV-2 protein. The company was awarded over $2 million by the Department

Alcon, the global leader in eye care, is pleased to announce the Canadian launch of AcrySof® IQ Vivity®, a first-of-its-kind, surgical lens designed to help cataract patients treat presbyopia, a common, age-related vision condition caused by the gradual loss of the eye’s ability to focus on close objects.

Pharma Logistics and ConsortiEX, market leaders in serving the needs of pharmacies and hospitals, today announced the launch of their Strategic Collaboration Program.

Instrument Sales Increase 68%, Total Revenue Increases 7%, Operating Loss Decreases 23% (Q/Q); Planned Release of Revolutionary UST System in Mid-2021 Expected to Drive Major Revenue Growth and Progression to Profitability Investor Conference Call Scheduled for Tuesday, November 17, 2020 at 4:30 PM EST

Global Superstar Featured in New Public Service Campaign Revealing How Advice from Her Mother Prior to Her Tragic Passing from Pancreatic Cancer Is Giving Her Inspiration to Advocate for Others

Relmada Therapeutics, Inc. (Nasdaq: RLMD), a clinical-stage company developing novel therapies for the treatment of central nervous system (CNS) diseases, today announced that Sergio Traversa , Chief Executive Officer of Relmada, will participate in the following upcoming virtual investor conferences: